Wegovy Side Effects

The drug-specific companion to The Side Effects Nobody Preps You For. Same molecule as Ozempic, different product, and the difference matters more than people expect.

What is different about Wegovy

It climbs higher. Wegovy titrates to 2.4 mg — the highest semaglutide dose in routine use, and meaningfully above where most people on Ozempic sit. More drug means more of everything, including the gastrointestinal effects.

It climbs in five fixed steps. Which reshapes the whole experience. Side effects on Wegovy do not accumulate in a steady line; they arrive in five distinct waves, each following an increase, each settling over about a week. The month between increases is usually the easy part.

That structure means the side-effect question is really a titration question, asked five times: go up, or hold?

The loss is faster, which brings its own problems. Wegovy is prescribed for weight management, and mean loss in STEP 1 was around 15% at 68 weeks. Rapid weight loss from any cause carries consequences that are not drug effects at all but arrive on the drug’s schedule — gallstones, and the hair shedding that turns up around month four.

No hypoglycemia complication in most people. Unlike Ozempic’s typical patient, most people on Wegovy are not also taking insulin or a sulfonylurea, so that risk is largely absent. If you are, the same warning applies.

The five waves

Each escalation produces roughly the same shape: onset within 24 hours, peak around day two or three, resolution over about a week. That timing tracks the concentration curve — blood levels peak one to three days after injection, not immediately.

Knowing this in advance is most of what makes it tolerable. Almost every person I have seen quit in month two quit during an ordinary, expected, self-limiting week that nobody had warned them about.

The consequences of losing weight quickly

Two things that get blamed on the drug and are really about the rate.

Gallbladder disease. Rapid weight loss increases gallstone risk regardless of method, and there is a gallbladder signal in the GLP-1 data. New right-upper-quadrant pain, especially after fatty meals, with or without fever or jaundice, needs evaluation promptly.

Hair shedding. Usually telogen effluvium — a delayed, diffuse, temporary shed triggered by the deficit rather than by the molecule. It starts two to four months after the trigger, which is why it feels like it came from nowhere, and regrows over six to nine months. Protein, avoiding an extreme deficit, and checking ferritin are the interventions that help.

The red flags

Not tolerability problems. These belong on a phone, not in a plan.

• Severe, persistent abdominal pain radiating to the back, often with vomiting — possible pancreatitis. Stop and seek care.
• Right-upper-quadrant pain, fever, or jaundice — possible gallbladder disease.
• Vomiting or diarrhoea you cannot keep ahead of — dehydration and kidney injury.
• Any sedation or procedure — tell the anaesthetist, unprompted, in pre-op.

Managing the five waves

Slow the titration. This is the lever, and it is under-used. The label explicitly permits delaying escalation if a dose is not tolerated. Eight or twelve weeks at a step instead of four is normal, and there is no prize for reaching 2.4 mg on schedule. I would far rather someone arrive at 1.7 mg comfortably and stay there than reach 2.4 mg and quit.

Eat for the window. Smaller meals, less fat, nothing fried, in the two to three days after the shot. Stop at first fullness.

Get ahead of constipation rather than waiting it out.

Protect protein. 1.2–1.6 g per kg per day. This is not a side-effect measure in the obvious sense, but under-eating protein produces the fatigue, the hair shedding, and much of the misery that gets attributed to the drug. I have argued this at length in Muscle Is the Whole Game.

Know your own pattern before the next increase. This is the part that generalises least well from an article and most from a record.

It is also where I think a structured tool does real work. The Zenday App builds a customised side-effect plan from your own logged pattern — your timing, your symptoms, your dose — rather than handing you the same generic advice everyone gets, and the management protocols behind it were written by its clinical team. More than a million people use it.

The reason that matters specifically on Wegovy is the escalation structure. You face the same decision five times, and each time the useful evidence is how the last increase actually went — not how you remember it going four weeks later, in a fifteen-minute appointment, when memory has smoothed it. Arriving at that conversation with the real pattern is what turns “it was fine, I think” into a decision.

To be clear about the boundary: it manages tolerability. It does not replace your prescriber, and nothing on the red-flag list above should ever be routed through an app.

The three sentences

1. If the side effects are bad, the answer is usually a slower titration — call before you quit.
2. Severe persistent abdominal pain, or vomiting you cannot stay ahead of, means same-day contact.
3. Tell every clinician you see, including your surgeon and anaesthetist, that you take this.